Skip to content
FIND A HEALTH VALLEY ACTOR

AzureCell Therapies and Myriad Optics Awarded by Gebert Rüf Stiftung Innobooster Programme

GRS

Two Swiss Health Valley projects, from EPFL and University of Geneva, got a CHF 150’000 Innobooster grant from Gebert Rüf Stiftung programme: AzureCell Therapies and Myriad Optics.   AzureCell Therapies | Bilal Fares, University of Geneva Every 9 min, a new patient is diagnosed with Parkinson’s, a condition long considered incurable due to the irreversible loss…

Read More

Breaking Through Cancer’s Soft Defense: A Revolutionary Swiss Approach

Leenaards

Swiss researchers from EPFL, University of Geneva, and HUG hospitals are pioneering a groundbreaking strategy to overcome immunotherapy resistance by targeting cancer cells’ physical properties rather than their biology. The project received a CHF 1,4 million grant from Foundation Leenaards. “Our approach targets the mechanical properties of cancer cells by making their membranes stiffer, which…

Read More

planetary Switzerland: Scaling Mycoprotein Production Through Strategic Expansion

Planetary - David Brandes

Geneva-based biomanufacturing platform planetary is making significant strides in the alternative protein sector through a combination of strategic acquisitions, IP breakthroughs, retail partnerships, and government-backed expansion plans. The company has positioned itself as continental Europe’s only viable industrial mycoprotein producer, leveraging cutting-edge fermentation technology to create sustainable protein alternatives.   Strategic Acquisition of Libre Foods…

Read More

Two UNIGE researchers receive ERC grants

Unige - ERC

Prof. Pedro Herrera and Prof. Giuseppe Iacobucci both receive €150,000 in funding from the European Research Council (ERC) The European Research Council (ERC) announced the first group of researchers who will receive ERC Proof of Concept Grants in 2025. Two scientists from UNIGE are among those selected. Pedro Herrera, Professor in the Department of Genetic…

Read More

Nestlé Partners with IBM Research to Use AI in New Packaging Developments

Nestlé et IBM

Nestlé R&D is partnering with IBM Research to develop new tools that leverage the power of Artificial Intelligence and deep tech to bring breakthrough innovations to life. This research collaboration has led to the development of a generative AI tool that can identify novel high-barrier packaging materials.   Packaging helps to protect food and beverages while also preventing food waste. Nestlé tries to…

Read More

Day One Innovation Showcase

Day One Innovation Showcase

The Day One Innovation Showcase for healthtech promising startups is taking place on 15 December 2026 in Basel The Showcase is an elite event, tailor-made for investors, startups and potential industry clients, fostering networking, pitching, business exploration and a deep dive into the healthtech startup ecosystem. During the two-day program you will: 🗓 15 December…

Read More

ADM Opens R&D Center Dedicated to Animal Health and Wellness at Biopôle

ADM

Located ar Biopôle Lausanne in canton of Vaud, the new innovation hub will focus on advanced microbiome research for farm and companion animals   ROLLE, Switzerland—ADM (NYSE: ADM), a global leader in innovative solutions from nature, has opened a new research and development (R&D) center focused on advancing research into animal microbiomes, and developing tailored…

Read More

First Ventures

First Ventures

Apply before 1 December 2026 to First Ventures and get up to CHF 150’000 from Gebert Rüf Stiftung With «First Ventures», Gebert Rüf Stiftung supports bachelor’s and master’s students of Swiss Universities of Applied Sciences UAS who are developing an innovative business idea out of their studies towards the market. The support includes progressing contributions…

Read More

Fribourg Scientists Help Uncover Erythrocytosis Mutation

Blood Red Cells

An international team of researchers, including five scientists from the University of Fribourg, has identified genetic mutations responsible for certain forms of erythrocytosis — a rare condition in which the body overproduces red blood cells. The findings shed new light on an often-misunderstood disease that can lead to dangerous blood clots and other serious health…

Read More

Startup Nights

Startup Nights

Startup Nights, one of the largest startup event in Switzerland, is taking place on 5-6 November 2026 in Winthertur Startup Night Pitching showcases startups tackling global challenges with technologies that deliver tangible social or ecological value! A unique opportunity to gain visibility, build recognition, and showcase your solution to investors, leading innovation experts in Switzerland,…

Read More